ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $60.5M

      Shares

      125k

      % of Portfolio

      0.02%

      Average Buy Price

      $98.3

      Avg closing price
      Price range

      33 Ken Fisher Medpace Holdings Trades

      Ken Fisher's position in Medpace Holdings is currently worth $60.5M. That's 0.02% of their equity portfolio (199th largest holding). The first Medpace Holdings trade was made in Q1 2017. Since then Ken Fisher bought shares twelve more times and sold shares on twenty occasions. The stake costed the investor $12.3M, netting the investor a gain of 391% so far.

      Avg closing price
      Price range
      Sold 29.8% shares (-53.2k shares) Q2 2025
      Avg closing price $300.15
      Price range $277.23 - $315.28
      Sold 2.6% shares (-4.76k shares) Q1 2025
      Avg closing price $336.74
      Price range $304.69 - $360.97
      Increased shares by 47.4% (+59k shares) Q4 2024
      Avg closing price $339.28
      Price range $308.93 - $363.58
      Increased shares by 6.9% (+8.01k shares) Q3 2024
      Avg closing price $379.87
      Price range $320.58 - $457.29
      Sold 3.0% shares (-3.57k shares) Q2 2024
      Avg closing price $396.01
      Price range $372.00 - $424.34
      Sold 0.1% shares (-137 shares) Q1 2024
      Avg closing price $351.59
      Price range $284.87 - $413.31
      Sold 2.4% shares (-3.01k shares) Q4 2023
      Avg closing price $269.93
      Price range $227.52 - $312.68
      Increased shares by 1.5% (+1.87k shares) Q3 2023
      Avg closing price $255.77
      Price range $233.98 - $281.67
      Sold 1.0% shares (-1.19k shares) Q2 2023
      Avg closing price $207.72
      Price range $187.26 - $240.17
      Sold 12.8% shares (-18k shares) Q1 2023
      Avg closing price $206.82
      Price range $174.31 - $239.52
      Sold 53.9% shares (-164k shares) Q4 2022
      Avg closing price $199.79
      Price range $153.06 - $226.57
      Sold 7.0% shares (-22.9k shares) Q3 2022
      Avg closing price $159.57
      Price range $145.13 - $182.49
      Increased shares by 7.4% (+22.6k shares) Q2 2022
      Avg closing price $144.76
      Price range $130.20 - $168.03
      Sold 2.1% shares (-6.4k shares) Q1 2022
      Avg closing price $164.88
      Price range $138.87 - $214.31
      Sold 5.2% shares (-17k shares) Q4 2021
      Avg closing price $209.40
      Price range $182.74 - $227.90
      Increased shares by 12.0% (+35.3k shares) Q3 2021
      Avg closing price $182.39
      Price range $170.18 - $198.21
      Sold 0.2% shares (-728 shares) Q2 2021
      Avg closing price $172.59
      Price range $158.62 - $194.30
      Sold 0.8% shares (-2.41k shares) Q1 2021
      Avg closing price $152.95
      Price range $132.02 - $168.26
      Sold 3.2% shares (-9.83k shares) Q4 2020
      Avg closing price $126.04
      Price range $109.38 - $149.19
      Sold 14.8% shares (-53.2k shares) Q3 2020
      Avg closing price $115.63
      Price range $92.95 - $130.61

      News about Medpace Holdings Inc and Ken Fisher

      Here's Why Investors Should Buy ResMed (RMD) Stock Now

      Here's Why Investors Should Buy ResMed (RMD) Stock Now

      ResMed Inc. (RMD Quick QuoteRMD - Free Report) is gaining from the global supply of its cloud-connected platforms, AirSense10 and AirSense11. The MEDIFOX DAN...

      https://www.zacks.com https://www.zacks.com, over 1 year ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×